|
... | ||
|
||
|
||
|
|||||
浙江大學(xué)醫(yī)學(xué)院碩士研究生導(dǎo)師簡介:周天華 |
|||||
來源:浙江大學(xué) 更新:2007-5-30 考研論壇 | |||||
近期原始科學(xué)論文:(已被SCI雜志引用102次) 2.Zhou, T.,* Aumais, J., Liu, X., Yu-Lee, L. Y., and Erikson, R. L. (2003). A role for Plk1 phosphorylation of NudC in cytokinesis. Developmental Cell** 5, 127-138. (*兼通訊作者, ** Cell的姐妹刊物, 影響因子: 14.8). 3.Liu, X., Zhou, T., Yan, S., and Erikson, R. L. (2004). Molecular interaction of polo-like kinase 1 with mitotic kinesin-like protein CHO1/MKLP-1. Journal of Cell Science 117, 3233-3246. (影響因子: 7.2). 4.Liu, X., Yan, S., Zhou, T., Terada, Y., and Erikson, R. L. (2004). The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23, 763-776. 影響因子: 6.5). 5.Zhou, T. H., Ling, K., Guo J., Zhou, H., Wu, Y. L. Jing, Q., Ma, L., and Pei, G. (2000). Identification of a human brain-specific isoform of mammalian STE20-like kinase 3 that is regulated by cAMP-dependent protein kinase. Journal of Biological Chemistry 275, 2513-2519. (影響因子: 6.5). 6.Zhou, T. H.,* Wu, G. X.,* Lin, Y. M.,* Gao, H., and Pei, G. (2000). Significant down-regulation of alpha-albumin in human hepatoma and its implication. Cancer Letters 160, 229-236. (*共同第1作者, 影響因子: 2.6). 7.Wang, P., Wu, Y., Zhou, T. H., Sun, Y., and Pei, G. (2000). Identification of alternative splicing variants of the beta subunit of human Ca (2+)/calmodulin-dependent protein kinase II with different activities. FEBS Letters 475, 107-110. (影響因子: 3.6). 8.Yu, Q.M., Cheng, Z. J., Zhou, T. H., Cen, B., Guo, S. Q., and Pei, G. (1999). Molecular cloning of human beta arrestin1 cDNA, expression and function study. Acta Biochimica et Biophysica Sinica 31, 344-346. (影響因子: 0.5). 9.Lou, L. G., Zhou, T., Wang, P., and Pei, G. (1999). Modulation of Ca2+/Calmodulin-Dependent Protein Kinase II Activity by Acute and Chronic Morphine Administration in Rat Hippocampus: Differential Regulation of  and  Isoforms. Molecular Pharmacology 55, 557-563. (影響因子: 5.6). 10.Fan, G. H., Zhou, T. H., Zhang, W. B., and Pei, G. (1998). Suppression of Phospholipase C blocks Gi-mediated inhibition of adenylyl cyclase activity. European Journal of Pharmacology 341, 317-322. (影響因子: 2.3). 11.Yu, Q. M., Cheng, Z. J., Zhao, J., Zhou, T. H., Wu, Y. L., Ma, L., and Pei, G. (1998). Carboxyl terminal of rhodopsin kinase is required for the phosphorylation of photo-activated rhodopsin. Cell Research 8, 303-310. (影響因子: 1.7). 12.Zhou, T. H., Ren, X. H., Yin, D. L., Wu, Y. L., Li, M., Lu, C. Z., Wu, D. C., Wu, Y. Q., Peng, Y. Q., Wang, Y. P., Ma, L., and Pei, G. (1997). Retardation of pain development: a case of recovery from congenital insensitivity to pain. Acta Anaesthesiologica Scandinavica 41, 1077-1079. (影響因子: 1.7). |
|||||
文章錄入:凌云 責任編輯:凌云 | |||||
【發(fā)表評論】【加入收藏】【告訴好友】【打印此文】【關(guān)閉窗口】 |
評論僅代表網(wǎng)友觀點,與本站無關(guān),請遵守相關(guān)法律 |
評論加載中... |
| 設(shè)為首頁 | 加入收藏 | 聯(lián)系站長 | RSS導(dǎo)航頁面 | 版權(quán)申明 |網(wǎng)站地圖 | 醫(yī)學(xué)論壇 | | |||||
|